As of April 29, 2025, Turnstone Biologics (TSBX) has a market cap of $7.819 million USD. According to our data, Turnstone Biologics is ranked No.8891 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $7.82 M |
-31.98%
|
Dec 31, 2024 | $11.49 M |
-80.47%
|
Dec 29, 2023 | $58.86 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.21 B |
48.381 M
|
![]() France
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$55.18 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
Market Cap | = | TSBX Stock Price | * | TSBX Shares Outstanding |
= | $0.34 | * | 23.14 M | |
= | $7.82 M |